Lineage Cell Therapeutics (LCTX) Revenue (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.90% |
| Dec 31, 2025 | 79.52% |
| Sep 30, 2025 | 33.13% |
| Jun 30, 2025 | 84.09% |
| Mar 31, 2025 | -47.63% |
| Dec 31, 2024 | -24.11% |
| Sep 30, 2024 | 168.39% |
| Jun 30, 2024 | -2.49% |
| Mar 31, 2024 | -30.84% |
| Dec 31, 2023 | 67.58% |
| Sep 30, 2023 | -61.36% |
| Jun 30, 2023 | 35.16% |
| Mar 31, 2023 | 24.60% |
| Dec 31, 2022 | -36.12% |
| Sep 30, 2022 | -34.15% |
| Jun 30, 2022 | -13.06% |
| Mar 31, 2022 | -89.53% |
| Dec 31, 2021 | 2,102.64% |
| Sep 30, 2021 | 343.36% |
| Jun 30, 2021 | 30.95% |